196 related articles for article (PubMed ID: 11982959)
1. Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.
Lyu RK; Chen WH; Hsieh ST
Ther Apher; 2002 Apr; 6(2):163-6. PubMed ID: 11982959
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
Okamiya S; Ogino M; Ogino Y; Irie S; Kanazawa N; Saito T; Sakai F
Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
[TBL] [Abstract][Full Text] [Related]
3. [Apheresis therapy in Guillain-Barré syndrome].
Nagayama H; Katayama Y
Nihon Rinsho; 2008 Jun; 66(6):1195-9. PubMed ID: 18540370
[TBL] [Abstract][Full Text] [Related]
4. Ability to remove immunoglobulins and antiganglioside antibodies by double filtration plasmapheresis in Guillain-Barré syndrome: is it equivalent to plasma exchange?
Tagawa Y; Yuki N; Hirata K
Ther Apher; 1997 Nov; 1(4):336-9. PubMed ID: 10225726
[TBL] [Abstract][Full Text] [Related]
5. Experience of double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.
Chen WH; Yeh JH; Chiu HC
J Clin Apher; 1999; 14(3):126-9. PubMed ID: 10540367
[TBL] [Abstract][Full Text] [Related]
6. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
Tagawa Y; Yuki N
Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and complication rates for double-filtration plasmapheresis in patients with Guillain-Barré syndrome.
Lin JH; Tu KH; Chang CH; Chen YC; Tian YC; Yu CC; Hung CC; Fang JT; Yang CW; Chang MY
Transfus Apher Sci; 2015 Feb; 52(1):78-83. PubMed ID: 25544386
[TBL] [Abstract][Full Text] [Related]
8. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency.
Oczko-Walker M; Manousakis G; Wang S; Malter JS; Waclawik AJ
J Clin Neuromuscul Dis; 2010 Dec; 12(2):55-61. PubMed ID: 21386771
[TBL] [Abstract][Full Text] [Related]
9. Ability to remove immunoglobulins and anti-ganglioside antibodies by plasma exchange, double-filtration plasmapheresis and immunoadsorption.
Tagawa Y; Yuki N; Hirata K
J Neurol Sci; 1998 Apr; 157(1):90-5. PubMed ID: 9600682
[TBL] [Abstract][Full Text] [Related]
10. Plasma adsorption in critical care.
Yang KS; Kenpe K; Yamaji K; Tsuda H; Hashimoto H
Ther Apher; 2002 Jun; 6(3):184-8. PubMed ID: 12109940
[TBL] [Abstract][Full Text] [Related]
11. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
[TBL] [Abstract][Full Text] [Related]
12. Plasma exchange for Guillain-Barré syndrome.
Raphaël JC; Chevret S; Hughes RA; Annane D
Cochrane Database Syst Rev; 2002; (2):CD001798. PubMed ID: 12076424
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of anti-glycolipid antibody-associated neuropathy].
Yuki N
Rinsho Shinkeigaku; 1999 Dec; 39(12):1232-4. PubMed ID: 10791085
[TBL] [Abstract][Full Text] [Related]
14. CSF filtration is an effective treatment of Guillain-Barré syndrome: a randomized clinical trial.
Wollinsky KH; Hülser PJ; Brinkmeier H; Aulkemeyer P; Bössenecker W; Huber-Hartmann KH; Rohrbach P; Schreiber H; Weber F; Kron M; Büchele G; Mehrkens HH; Ludolph AC; Rüdel R
Neurology; 2001 Sep; 57(5):774-80. PubMed ID: 11552002
[TBL] [Abstract][Full Text] [Related]
15. Plasma exchange and double filtration plasmapheresis in chronic glomerulonephritis patients with Guillain-Barre syndrome.
Nakamura T; Ushiyama C; Hirokawa K; Osada S; Inoue T; Shimada N; Koide H
Ren Fail; 2002 May; 24(3):387-9. PubMed ID: 12166708
[No Abstract] [Full Text] [Related]
16. Dissociation between titer of anti-ganglioside antibody and severity of symptoms in a case of Guillain-Barré syndrome with treatment-related fluctuation.
Inoue N; Kunishige M; Yoshida S; Oshima Y; Ohnishi Y; Kuroda Y; Asano A; Yoshino H; Matsumoto T; Mitsui T
J Neurol Sci; 2003 Jun; 210(1-2):105-8. PubMed ID: 12736098
[TBL] [Abstract][Full Text] [Related]
17. Functional outcomes following inpatient rehabilitation of Guillain-Barré syndrome patients: Intravenous immunoglobulins versus plasma exchange.
Bondi M; Engel-Haber E; Wolff J; Grosman-Rimon L; Bloch A; Zeilig G
NeuroRehabilitation; 2021; 48(4):543-551. PubMed ID: 34024788
[TBL] [Abstract][Full Text] [Related]
18. Plasma exchange for Guillain-Barré syndrome.
Raphaël JC; Chevret S; Hughes RA; Annane D
Cochrane Database Syst Rev; 2001; (2):CD001798. PubMed ID: 11406009
[TBL] [Abstract][Full Text] [Related]
19. [Plasmapheresis in Guillain-Barre syndrome].
Carbajal-Ramírez A; Castañón-González JA; Osvaldo-Talavera J; de la Torre-Nieto ML; León-Gutiérrez MA
Gac Med Mex; 2002; 138(6):527-31. PubMed ID: 12532617
[TBL] [Abstract][Full Text] [Related]
20. Plasmapheresis versus plasma perfusion in acute Guillain-Barré syndrome.
Morosetti M; Meloni C; Taccone Gallucci M; Rossini PM; Felicioni R; Palombo G; Boccasena P; Casciani CU
ASAIO J; 1994; 40(3):M638-42. PubMed ID: 8555592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
